NXI Therapeutics

Description: NXI Therapeutics develops next-gen selective immunosuppressive drugs for autoimmune diseases and transplantations.

Country: Switzerland

Based in: Basel

Founded: 2021

Funding Stage: Pre-Seed

Tags: ['Health']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.